首页> 外文期刊>Nature >A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance
【24h】

A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance

机译:调节性T细胞库的扩展机制及其在自我耐受中的作用

获取原文
获取原文并翻译 | 示例
       

摘要

T-cell receptor (TCR) signalling has a key role in determining T-cell fate. Precursor cells expressing TCRs within a certain low-affinity range for complexes of self-peptide and major histocompatibility complex (MHC) undergo positive selection and differentiate into naive T cells expressing a highly diverse self-MHC-restricted TCR repertoire. In contrast, precursors displaying TCRs with a high affinity for 'self' are either eliminated through TCR-agonist-induced apoptosis (negative selection)(1) or restrained by regulatory T (T-reg) cells, whose differentiation and function are controlled by the X-chromosome-encoded transcription factor Foxp3 (reviewed in ref. 2). Foxp3 is expressed in a fraction of self-reactive T cells that escape negative selection in response to agonist-driven TCR signals combined with interleukin 2 (IL-2) receptor signalling. In addition to Treg cells, TCR-agonist-driven selection results in the generation of several other specialized T-cell lineages such as natural killer T cells and innate mucosal-associated invariant T cells(3). Although the latter exhibit a restricted TCR repertoire, Treg cells display a highly diverse collection of TCRs(4-6). Here we explore in mice whether a specialized mechanism enables agonist-driven selection of T-reg cells with a diverse TCR repertoire, and the importance this holds for self-tolerance. We show that the intronic Foxp3 enhancer conserved noncoding sequence 3 (CNS3) acts as an epigenetic switch that confers a poised state to the Foxp3 promoter in precursor cells to make T-reg cell lineage commitment responsive to a broad range of TCR stimuli, particularly to suboptimal ones. CNS3-dependent expansion of the TCR repertoire enables T-reg cells to control self-reactive T cells effectively, especially when thymic negative selection is genetically impaired. Our findings highlight the complementary roles of these two main mechanisms of self-tolerance.
机译:T细胞受体(TCR)信号传导在确定T细胞命运方面具有关键作用。表达自身肽和主要组织相容性复合体(MHC)的复合体在一定低亲和力范围内表达TCR的前体细胞经过阳性选择,并分化为表达高度​​自我MHC限制性TCR组成谱的幼稚T细胞。相比之下,显示出对'自我'具有高度亲和力的TCR的前体通过TCR激动剂诱导的凋亡(负选择)(1)消除,或受调节性T(T-reg)细胞限制,后者的分化和功能受X染色体编码的转录因子Foxp3(参见参考文献2)。 Foxp3在一部分自我反应性T细胞中表达,该细胞可响应激动剂驱动的TCR信号与白介素2(IL-2)受体信号传导而逃避负选择。除Treg细胞外,TCR激动剂驱动的选择还导致产生其他几种专门的T细胞谱系,例如自然杀伤性T细胞和与粘膜相关的先天性不变T细胞(3)。尽管后者显示出受限的TCR组成,但Treg细胞显示出高度多样化的TCR集合(4-6)。在这里,我们在小鼠中探索一种特殊的机制是否能够通过激动剂驱动的T-reg细胞选择具有多种TCR组成的细胞,以及这对于自我耐受的重要性。我们显示,内含子Foxp3增强子保守的非编码序列3(CNS3)作为表观遗传开关,赋予前体细胞Foxp3启动子一个平衡的状态,以使T-reg细胞谱系对大范围的TCR刺激作出反应,特别是对次优的。依赖CNS3的TCR组成部分的扩增使T-reg细胞能够有效地控制自身反应性T细胞,尤其是在胸腺阴性选择因遗传受损时。我们的发现突出了这两个主要的自我宽容机制的互补作用。

著录项

  • 来源
    《Nature》 |2015年第7580期|132-136|共5页
  • 作者单位

    Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA|Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr, New York, NY 10065 USA;

    Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA|Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr, New York, NY 10065 USA;

    Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Moscow 117997, Russia|Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia|Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic;

    Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Moscow 117997, Russia|Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic;

    Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA;

    Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA|Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr, New York, NY 10065 USA;

    Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA|Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr, New York, NY 10065 USA;

    Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA|Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr, New York, NY 10065 USA;

    Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA|Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr, New York, NY 10065 USA;

    Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA;

    Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA;

    Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Moscow 117997, Russia|Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia|Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic;

    Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA|Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr, New York, NY 10065 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:52:46

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号